Purchase Order 75N91024P00145
Award Date 2/20/24
Potential Completion Date 8/19/24
Potential Value $38K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Northbrook, IL 60062, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Genus Biosystems Inc., a for-profit organization, for $23,520.00 to provide lab testing services. The contract has a completion date of November 1, 2024 and was awarded on May 1, 2024. The place of performance is Northbrook, IL 60062, USA. This contract award is not associated with any set-aside designation.</p>
- The U.S. government awarded a $3,294 firm fixed-price purchase order to Genus Biosystems Inc. for microarray services on July 23, 2009, with an ultimate completion date of August 28, 2009. The contract was executed without a set-aside designation, allowing the vendor to compete in the open market. The work was performed at Genus Biosystems' facility in Northbrook, Illinois. Genus Biosystems Inc., a for-profit laboratory services provider specializing in genomics and transcriptomics analysis, has...
- This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
- The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $23,598.00 on March 25, 2016, with ultimate completion on March 26, 2017. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The awardee provides scientific consultation and data analysis services in support of biomedical research programs at the National Cancer Institute, including scientific input, algorithm development, and imaging support for cancer research...
- <p>The National Cancer Institute issued a delivery order to Genepria Consulting Inc. on August 16, 2018, with a ceiling value of $17,250.00 under firm fixed price terms.</p> <p>Place of performance is Bethesda, Maryland. The order was scheduled for ultimate completion on September 16, 2019. No set-aside was used for this delivery order.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $219,720.00 firm fixed price purchase order to Novogene Corp Inc., a minority-owned small business, to conduct RNA sequencing and bioinformatics analysis. The work supports research into identifying biomarker signatures of radiation exposure and organ-specific radiation injury using samples from a non-human primate model and human organ-on-a-chip system. The contract requires a...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $21,657 purchase order to Genscript USA Inc. to produce eight BM306 protein constructs. The firm fixed price contract has a period of performance from July 17, 2023 through September 1, 2023 and will be performed in Piscataway, New Jersey. The NCI supports basic and clinical cancer research across its various centers and divisions to better understand, diagnose, and treat...
- <p>The National Cancer Institute awarded a purchase order to Arraystar Inc. for $31,692.00 on February 10, 2015, for microRNA next-generation sequencing services on 36 pancreatic neuroendocrine tumor samples. Work is performed in Rockville, Maryland. The order carries a firm fixed price and an ultimate completion date of April 15, 2015. The purchase order was funded through de-obligation of FY2015 expiring lines.</p>
- <p>The National Cancer Institute awarded a purchase order to Genscript USA Inc. for sequencing services valued at $14,558.16, issued on January 14, 2020, with final completion due February 12, 2020. Work is performed in Bethesda, Maryland. The order carries firm fixed pricing and no set-aside designation.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,102.75 firm fixed price contract to 10X Genomics, Inc. for single cell RNA sequencing on provided RNA samples. 10X Genomics will perform the requested 5' prime single cell RNA sequencing services at their Pleasanton, California facility between February 2nd and 28th, 2023. The National Cancer Institute seeks to advance cancer research and this contract will provide genomic analysis...